Chinese Biotech Firm Duoning Biotechnology Closes Nearly $15M Series A+ Round

Duoning Biotechnology, a Chinese biotech firm that focuses on providing serum-free cell culture medium, has raised nearly RMB100 million (US$14.88 million) in a series A+ round of financing, according to a statement released on Thursday.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets